Emerald Advisers, LLC Bridge Bio Pharma, Inc. Transaction History
Emerald Advisers, LLC
- $2.23 Billion
- Q2 2024
A detailed history of Emerald Advisers, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 666,344 shares of BBIO stock, worth $17 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
666,344
Previous 699,083
4.68%
Holding current value
$17 Million
Previous $21.6 Million
21.92%
% of portfolio
0.76%
Previous 0.92%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$791 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$640 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$317 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$154 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.77B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...